-+ 0.00%
-+ 0.00%
-+ 0.00%

ARS PHARMACEUTICALS - REDUCED Q3 SG&A EXPENSES; REAFFIRMS PATH TO CASH FLOW BREAKEVEN BY YEAR-END 2027

Reuters·11/05/2026 21:01:05

Please log in to view news